Britannia Life Sciences Inc stock forecast
Britannia Life Sciences Inc (L020) Stock Forecast & Price Target
L020 Analyst Ratings
L020 Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | €0.04→€0.04 | hold | 44.96%Upside | Reiterated | 09/26/26 | ||
| Google Health Care CA | TipRanks - Google | €0.04→€0.04 | hold | 42.76%Upside | Reiterated | 09/26/26 | ||
| Anthropic Health Care CA | TipRanks - Anthropic | €0.04→€0.04 | hold | 36.17%Upside | Reiterated | 09/26/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | €0.04→€0.04 | hold | 44.96%Upside | Reiterated | 09/26/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | €0.04→€0.04 | sell | 36.17%Upside | Downgraded | 09/26/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | €0.05→€0.04 | hold | 47.15%Upside | Reiterated | 09/26/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | HoldReiterated€0.04→€0.04 | 09/26/26 | 44.96%Upside | ||
| Google Health Care CATipRanks - Google | HoldReiterated€0.04→€0.04 | 09/26/26 | 42.76%Upside | ||
| Anthropic Health Care CATipRanks - Anthropic | HoldReiterated€0.04→€0.04 | 09/26/26 | 36.17%Upside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldReiterated€0.04→€0.04 | 09/26/26 | 44.96%Upside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | SellDowngraded€0.04→€0.04 | 09/26/26 | 36.17%Upside | ||
| xAI - Grok-4.3TipRanks - xAI | HoldReiterated€0.05→€0.04 | 09/26/26 | 47.15%Upside |
Best Analysts Covering Britannia Life Sciences Inc
Copying DeepSeek Health Care CA's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -7.60% per trade.
Copying DeepSeek Health Care CA's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -7.60% per trade.
Copying DeepSeek Health Care CA's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -7.60% per trade.
L020 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, L020 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. L020 average Analyst price target in the past 3 months is ―.
L020 Financial Forecast
L020 Sales Forecast
Next quarter’s sales forecast for L020 is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 62.97K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
